Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 85,366 | 60,757 | 57,244 | 53,113 | 43,089 |
| Cost of Goods | 9,946 | 11,195 | 9,665 | 7,643 | 5,890 |
| Gross Profit | 75,420 | 49,562 | 47,579 | 45,470 | 37,199 |
| Operating Expenses | 40,757 | 18,956 | 23,142 | 17,544 | 20,723 |
| Operating Income | 35,609 | 30,801 | 25,102 | 28,569 | 17,366 |
| Other Income | 1,704 | 2,207 | 905 | -324 | 93 |
| Pre-tax Income | 37,313 | 33,008 | 26,007 | 28,245 | 17,459 |
| Income Tax | 7,745 | 7,537 | 3,259 | 6,626 | 4,218 |
| Net Income Continuous | 29,568 | 25,471 | 22,748 | 21,619 | 13,241 |
| Net Income | $29,568 | $25,471 | $22,748 | $21,619 | $13,241 |
| EPS Basic Total Ops | 0.28 | 0.24 | 0.22 | 0.21 | 0.13 |
| EPS Basic Continuous Ops | 0.28 | 0.24 | 0.22 | 0.21 | 0.13 |
| EPS Diluted Total Ops | 0.26 | 0.23 | 0.20 | 0.20 | 0.12 |
| EPS Diluted Continuous Ops | 0.26 | 0.22 | 0.20 | 0.20 | 0.12 |
| EBITDA(a) | $42,209 | $31,416 | $25,655 | $28,606 | $17,400 |